EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IgG N-Glycosylation Is Altered in Coronary Artery Disease

Barbara Radovani, Frano Vučković, Aldo P Maggioni iD, Ele Ferrannini iD, Gordan Lauc iD, Ivan Gudelj iD

Biomolecules · 2023

DOI: 10.3390/biom13020375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Barbara Radovani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia. Hauptthemen laut MEDLINE: Immunoglobulin G, Coronary Artery Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery disease (CAD) is the most common cardiovascular disease (CVD), and previous studies have shown a significant association between N-glycosylation, a highly regulated posttranslational modification, and the development of atherosclerotic plaques. Our aim was to determine whether the N-glycome of immunoglobulin G (IgG) is associated with CAD, as N-glycans are known to alter the effector functions of IgG, which may enhance the inflammatory response in CAD. Therefore, in this study, we isolated IgG from subjects with coronary atherosclerosis (CAD+) and from subjects with clean coronaries (CAD−). The purified IgGs were denatured and enzymatically deglycosylated, and the released and fluorescently labelled N-glycans were analysed by ultra-high performance liquid chromatography based on hydrophilic interactions with fluorescence detection (HILIC-UHPLC-FLR). Sex-stratified analysis of 316 CAD− and 156 CAD+ cases revealed differences in IgG N-glycome composition. The most notable differences were observed in women, where the presence of sialylated N-glycan structures was negatively associated with CAD. The obtained chromatograms provide insight into the IgG N-glycome composition in CAD as well as the biomarker potential of IgG N-glycans in CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GCoronary Artery DiseaseHumansFemaleGlycosylationChromatography, High Pressure LiquidPolysaccharides

Stichwörter der Autor:innen

N-glycanscardiovascular diseasecoronary artery diseaseglycosylationimmunoglobulin Ginflammation

Substanzen

Immunoglobulin GPolysaccharides

Autor:innen und Institutionen

  • Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
  • Genos Glycoscience Research Laboratory, 10000 Zagreb, Croatia.
  • Heart Care Foundation ANMCO Research Center, 50100 Florence, Italy.
  • CNR Institute of Clinical Physiology, 56100 Pisa, Italy.
  • Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Aldo P Maggioni, Ele Ferrannini, Gordan Lauc, Ivan Gudelj

Förderung

  • Croatian Science Foundation

Zitieren

APA

Radovani, B., Vučković, F., Maggioni, A. P., Ferrannini, E., Lauc, G., & Gudelj, I. (2023). IgG N-Glycosylation Is Altered in Coronary Artery Disease. Biomolecules. https://doi.org/10.3390/biom13020375

Vancouver

Radovani B, Vučković F, Maggioni AP, Ferrannini E, Lauc G, Gudelj I. IgG N-Glycosylation Is Altered in Coronary Artery Disease. Biomolecules. 2023. doi:10.3390/biom13020375

BibTeX
@article{Radovani2023,
  author = {Radovani, Barbara and Vučković, Frano and Maggioni, Aldo P and Ferrannini, Ele and Lauc, Gordan and Gudelj, Ivan},
  title = {IgG N-Glycosylation Is Altered in Coronary Artery Disease},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13020375}
}
Kostenlos starten →